Abstract 593: DCC-3084, a brain penetrant RAF dimer inhibitor, broadly inhibits BRAF class I, II, and III alterations leading to growth inhibition of intracranially implanted tumors in preclinical models
Al-Ani, Gada, Bulfer, Stacie L., Zwicker, Jefferey D., Crawley, Chase K., Elliot, Kristin M., Javed, Salim, Groer, Qi, Hood, Molly M., Large, Joshua W., Luther, Kylie, Romero, Yeni K., Stanley, Forrest A., Tanner, Daniel C., Telikepalli, Hanumaiah, Le Bourdonnec, Bertrand, Smith, Bryan D., Flynn, Daniel L.
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article